9 insiders have filed at NKTR since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.
| name | role | reported stake | % of company | buys (3y) | sells (3y) |
|---|---|---|---|---|---|
| Deep Track Capital, Lp | 10% owner | 18.34M | 74.159% | 1 sells $100k | |
| Deep Track Biotechnology Master Fund, Ltd. | 10% owner | 18.34M | 74.159% | 1 sells $100k | |
| Kroin David | 10% owner | 18.34M | 74.159% | 1 sells $100k | |
| Chess Robert | Director | 259.5k | 1.049% | 2 sells $30k | |
| Robin Howard W | President & CEO | 75.5k | 0.305% | 25 sells $1.3M | |
| Ajer Jeffrey Robert | Director | 34.2k | 0.138% | 1 sells $3k | |
| Curet Myriam | Director | 27.4k | 0.111% | 1 sells $3k | |
| Wilson Mark Andrew | Chief Legal Officer | 21.6k | 0.087% | 12 sells $154k | |
| Zalevsky Jonathan | Chief R&d Officer | 21.2k | 0.086% | 18 sells $419k |
Full register at boothcheck.com/insiders/NKTR. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.